It has been the cause of infamous international foodborne disease outbreaks and yet it is the most studied bacterium in science, an essential part of the human digestive tract, and a backbone of the biotech industry. To enhance public understanding of the bacterium Escherichia coli, the American Academy of Microbiology brought together the nation's leading experts to consider and answer some of the most frequently asked questions about this multifaceted microorganism.
"The story of E. coli, what we are trying to tell in this report, is really much larger than just its role as a pathogen. It's been such a large component of research for so long so much of what we know about biology has come from studying E. coli," says Michael Doyle of the University of Georgia Center for Food Safety, a member of the steering committee.
The report, "FAQ E.coli: Good, Bad and Deadly," is based on the deliberations of 13 of the nation's leading experts who met for one day in September 2011 to develop clear answers to frequently asked questions regarding the role of E. coli in scientific research, human health and foodborne disease.
Some of the questions considered by the report are:
- What is E. coli anyway?
- How has E. coli contributed to our understanding of biology?
- What does naturally occurring E. coli in our GI tract do?
- What is the difference between "good" E. coli that inhabits our GI tract and the "bad" E. coli that makes us sick?
- Why does E. coli make some people sick and not others?
- How does E. coli become pathogenic?
- How does our food become contaminated with E. coli?
- What steps are being taken to protect our food from contamination by pathogenic E. coli?
- What types of food are most commonly associated with E. coli, and why do there seem to be more cases of contamination recently?
Most answers begin with a simple paragraph summarizing what is known, followed by a more detailed explanation. In addition, spread throughout the report are sidebar boxes discussing issues related to the questions such as a list of Nobel Prizes awarded for work done on E. coli and a discussion of toxins created by the bacterium.
"FAQ E. coli: Good, Bad and Deadly" is the latest offering in a series of reports designed to provide a rapid response to emerging issues. Traditionally Academy reports are based on multi-day colloquia after which the final report can take up to a year to develop. The FAQ series are based on single-day meetings focused on specific questions after which a final report is published in two to three months.
"The Academy FAQ reports explain complex microbiological problems in a timely, balanced format that is easily understandable by the public, the media and policy makers," says Stanley Maloy of San Diego State University, who moderated the colloquium.
A PDF of "FAQ E. coli: Good, Bad and Deadly" can be found online at http://bit.ly/aamecolifaq
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Global Patients, Local Risks: Why Medical Tourism Demands Infection Preventionists’ Attention
June 16th 2025At APIC25, infection prevention leader Heather Stoltzfus, MPH, RN, CIC, will spotlight the growing risks and overlooked responsibilities associated with medical tourism. Her session urges infection preventionists to engage with a global health trend that directly impacts US care settings.